Navigation Links
Dr Stephan Rietiker Joins BioCeramic Therapeutics
Date:1/9/2009

LONDON, January 9 /PRNewswire/ -- UK medical technology company BioCeramic Therapeutics Ltd is delighted to announce that Dr Stephan Rietiker has joined the company's Board of Directors. Dr Rietiker is widely recognized as a leading authority in BioCeramic Therapeutics' targeted sectors, particularly as former President and CEO of Centerpulse (formerly Sulzer Medical). His appointment follows the recent appointment of another renowned figure, Sir Richard Sykes, as Chairman of its Board of Directors and strengthens the company's management as it embarks on a new fundraising round to take its products through clinical trials.

"Given my professional background as a healthcare executive and in particular at Centerpulse, my primary focus is on getting involved in companies with leading edge technologies. As R&D activities in the biomaterials' arena are visibly gaining momentum, I'm delighted to be part of this fascinating venture. I fully believe in the technology and its future potential. Hence, I look forward to supporting the management team in efficiently reaching its strategic milestones and in creating significant value, both for patients and shareholders."

BCT is a pioneer in the exciting new field of regenerative medicine, bringing together some of the world's best materials scientists doctors, biologists and chemists in both private and public sectors. BCT is developing two families of implants designed to promote tissue regeneration. Initial applications are in orthopaedics and oral care, with plans to extend this to a wide range of other tissues important in human diseases.

Daniel Green, BCT's CEO, said: "I am delighted to welcome Stephan to the team. His input will be invaluable as we look to move our first BCT pipeline products through to clinic. Currently we are both exploring several licencing opportunities and embarking on a new fundraising round."

    Corporate Inquiries:
    Daniel Green, CEO
    BioCeramic Therapeutics
    Level One, Bessemer Building (RSM)
    Exhibition Road
    London SW7 2AZ,UK
    Tel +44(0)20-7594-1326
    email: djg@bioceramictherapeutics.com
    web:http://www.bioceramictherapeutics.com


'/>"/>
SOURCE BioCeramic Therapeutics Ltd
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates
2. GEN Joins Charles Darwin 2009 Celebration
3. BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative
4. Maureen Mo Zilly Joins the Varian Medical Systems Government Affairs Team as Director, Federal Affairs
5. Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons
6. Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
7. Pharos Innovations Joins Partnership to Fight Chronic Disease
8. Recognized Dermatology Expert Dr. Zoe Draelos Joins Histogen Scientific Advisory Board
9. Ethan Weiss, M.D., Joins Bionovos Scientific Advisory Board
10. Benjamin Custodio Joins Millennium Biotechnologies to Expand International Sales
11. Jerome Wilson Joins PRA Internationals Late Phase Service Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) announced today that ... of United Therapeutics will provide an overview and update ... st Annual Health Care Conference. The ... at 10:00 a.m. Eastern Time, and can be accessed ...
(Date:4/27/2016)... ... 27, 2016 , ... Global Stem Cells Group CEO Benito Novas ... founder of GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received his ... transplantation for hematologic disorders and the suppression of graft vs. host disease (GVHD) under ...
(Date:4/26/2016)... ... April 26, 2016 , ... BaseHealth , the comprehensive ... company as Chief Business Officer. Arianpour, a genomics pioneer and visionary commercial leader ... most recently Chief Commercial Officer of Pathway Genomics. He has held senior executive ...
(Date:4/26/2016)... ... April 26, 2016 , ... BioFactura, Inc ., a ... round of financing. Healthy investor interest drove significant oversubscription of the original $1.5M ... known as biosimilars, to the advanced preclinical stages. , Chief Executive Officer and President, ...
Breaking Biology Technology:
(Date:3/9/2016)... , March 9, 2016  Crossmatch ® , ... enrollment solutions, today announced the addition of smart ... Altus multi-factor authentication platform. New contextual and ... to step-up security where it,s needed most — ... Washington, DC . --> ...
(Date:3/3/2016)... SOTO, Kansas , March 3, 2016 ... Oncimmune,s Early CDT®-Lung, a blood test to aid ... cancer Early CDT®-Lung test to its clients ... Early CDT®-Lung test to its clients which include ... a leader in early cancer detection, today announced a ...
(Date:3/1/2016)... FRANCISCO , March 1, 2016  (RSAC Booth ... year, but a whopping $118 billion is lost to ... to overzealous and inaccurate fraud detection. At the RSA ... in the way companies handle authentication by devaluing the ... and behavioral analytics. --> ...
Breaking Biology News(10 mins):